BIDANG PENYELIAAN
Molecular Imaging / Radiology And Imaging
PENERBITAN
2024:
The Utility of [18]F-Fluorocholine Positron Emission Computed Tomography and [18]F -Fluo rodeo xyglu cose Positron Emission Tomography–Computed Tomography in Evaluating Breast Cancer Phenotypes: A Pilot Study
2022:
Detection of Neuroendocrine Tumour of Sphenoid Sinus on the Gallium-68 DOTATATE PET/CT: A Rare Entity
2021:
Artificial intelligence-assisted tools for redefining the communication landscape of the scholarly world
2021:
Rare right gluteal hibernoma masquerading as a metastatic non-small cell lung carcinoma – a potential 18F FDG PET-CT pitfall
2021:
The utility of the standardized uptake value, metabolic tumor volume and total lesion glycolysis as predictive markers of recurrent breast cancer
2021:
A Rare Right Gluteal Hibernoma Masquerades as A Metastatic Non-small Cell Lung Carcinoma—A Potential 18F FDG PET-CT Pitfall
2020:
Perirectal metachronous recurrence of the hepatocellular carcinoma in the rectum on the 11C choline PET–CT
2019:
Adverse Effect of the Neuronal Cells and the Coronary Artery Endothelium in Extreme Environments—Roles of Advanced Molecular Imaging Markers
2019:
Chlorogenic acid intercalated Gadolinium?Zinc/Aluminium Layered Double Hydroxide and Gold nanohybrid for MR Imaging and Drug delivery
2018:
The association of FDG-PET (Suvmax) and inflammatory marker in predicting tumour aggressiveness
2018:
The value of 18F-fluorodeoxyglucose PET (18F-FDG PET) and MRI spectroscopy in underpinning suspicious breast cancer
2018:
PET/CT analysis of 21 patients with breast cancer: physiological distribution of18F-choline and diagnostic pitfalls
2018:
PET-MRI imaging of cellular trafficking of lipid metabolism and its association with inflammatory and genetic markers in breast cancer
2017:
Gadolinium-Doped Gallic Acid-Zinc/Aluminium-Layered Double Hydroxide/Gold Theranostic Nanoparticles for a Bimodal Magnetic Resonance Imaging and Drug Delivery System
2017:
THE NOVEL MOLECULAR IMAGING MARKERS OF 18F-FLUOROCHOLINE PET/CT CD47, miRNA-21 and miRNA-155 IN UNDERPINNING PATIENTS WITH BREAST CANCER
2017:
Dual tracer 18F FDG-FCH PET-CT markers and gene expression profiling in the evaluation of an aggressive breast carcinoma
2017:
STANDARDISATION TECHNIQUES OF INDEPENDENT PET/CT MODALITIES UTILISING PET SUVMAX AS A POTENTIAL CONVERSION MARKER
2016:
Potential of 3?-Fluoro-3? Deoxythymidine as a Cellular Proliferation Marker in PET Oncology Examination
2015:
Diagnostic Performance of 68Ga-DOTATATE PET/CT, 18F-FDG PET/CT and 131I-MIBG Scintigraphy in Mapping Metastatic Pheochromocytoma and Paraganglioma
2015:
Mpacts of biological and procedural factors on the SUV of liver in 18F-FDG PET/CT
2015:
Pattern of calcification on CT and intense FDG PET uptake of a rare perineural Mantle Cell lymphoma; a potential of non-histological surrogate marker
2015:
Acute Thoracic Aortic Dissection (Stanford B): Challenges in Early Detection and Management
2015:
Acute Low Grade Fever and Atypical Pneumonia in Asian?s Epidemic Area-Melioidosis is an Unequivocally Important Diagnostic Differential.
2015:
The peculiar 18F -FDG -PET CT features of a colo ?colonic intussusception in adult with colorectal carcinoma
2014:
Localization and prediction of malignant potential in recurrent pheochromocytoma/paraganglioma (PCC/PGL) using 18F-FDG PET/CT
2013:
18[F] FDG-PET/CT is a useful molecular marker in evaluating tumour aggressiveness; a revised understanding of an in- vivo FDGPET imaging that alludes the alteration of cancer biology.
2012:
Imaging of nonthrombotic pulmonary embolism:Biological materials, nonbiological materials, and foreign bodies
2012:
Combined Ultrasound and IVU for the Management of Childhood Urolithiasis: A Case Report
2012:
A rare primary malignant vaginal melanoma detected by 18 [F]-FDG PET/CT imaging
2011:
Combined ultrasound and IVU for the management of the childhood urolithiasis; a case report
2011:
18[F] FDG-PET/CT is a useful molecular marker in evaluating thymoma aggressiveness
2010:
An intense 18F-FDG pulmonary microfocus on PET without detectable abnormality on CT: A manifestation of an iatrogenic FDG pulmonary embolus
2010:
18F-FDG PET/CT as a potential valuable adjunct to MRI in characterising the Brodie?s abscess
2010:
Significance of subcentimetre 18F-FDG PET/CT pulmonary abnormality in patients with known extrapulmonary malignancy
2009:
Avid 18F-FDG uptake of pectoralis major muscle: an equivocal sequela of strenuous physical exercise